Steve Ledger
Also at Serina Therapeutics
About
Steve Ledger is a seasoned executive with a strong background in finance and economics, evidenced by his educational achievements, including a Bachelor of Arts in Economics from the University of Connecticut.
He began his career in leadership roles at early-stage companies and later transitioned to significant advisory and operating positions. His multifaceted experience includes founding and managing investment firms as well as advising on value-based equity and debt securities.
At SER, his tenure began in June 2021 as the Chief Financial Officer, progressing to a board member role in December 2022. In March 2024, he was appointed Interim Chief Executive Officer and later confirmed as the permanent CEO, demonstrating his ability to drive strategic growth during transitional phases.
With over 35 years of experience in investment, board service, and operational leadership, his career reflects a commitment to both financial rigor and socially responsible initiatives, positioning him as a pivotal figure within the organization.